Karyopharm

KPTI NASDAQ
6.34
-0.09
-1.40%
已收盘, 17:55 06/24 EDT
开盘
6.43
昨收
6.43
最高
6.67
最低
6.02
成交量
108.45万
成交均量(3M)
92.12万
52周最高
21.71
52周最低
3.920
换手率
1.78%
市值
3.86亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Karyopharm KPTI股票价格,Karyopharm股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. It has discovered and is developing small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein, XPO1. The Company's lead drug candidate, selinexor (KPT-330), is an orally administered agent for the treatment of cancer indications with unmet clinical need, mainly hematologic malignancies. It is also engaged in the clinical development of selinexor in various solid tumor indications. Oral selinexor is being evaluated in multiple later-phase clinical trials in patients with relapsed and/or refractory hematological and solid tumor malignancies. Its lead drug candidate, oral selinexor (KPT-330), as well as verdinexor (KPT-335), KPT-8602 and KPT-9274 are in clinical development.
展开 >

最近浏览

名称
价格
涨跌幅